Delivery Order SPE2DB24D2100-SPE2DB25FBDWQ

Award Date 4/28/25
Potential Completion Date 4/29/25
Potential Value $2.2K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $5,165.19 firm fixed-price delivery order is for the supply of 4,559,592,394 Adderall XR 30 mg capsules in 100-count bottles. The contract has a completion date of January 13, 2023 and was awarded on January 12, 2023. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop...
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order worth $1,901.80 to Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical distribution company Amerisourcebergen Corporation. This order is for the supply of 4,563,828,106 Adderall XR 25 mg capsules and is part of a larger indefinite delivery contract (IDC) with a potential value of $999,999,999.00 awarded to Amerisourcebergen Drug Corp to provide pharmaceutical products and medical supplies to...
The U.S. Defense Logistics Agency (DLA) awarded a $1,154.28 firm fixed-price delivery order contract to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, to supply 4,564,292,646 units of Adderall XR 20 mg capsules. This order is part of a larger Indefinite Delivery Contract (IDC) valued up to $999,999,999.00 that Amerisourcebergen holds with DLA Troop Support Medical, which serves as the primary vehicle for the company to provide a wide range of pharmaceutical products and medical...
This is a federal contract award issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The $1,791.87 firm fixed-price delivery order is for the supply of Adderall XR 10 mg capsules. The contract has an ultimate completion date of May 12, 2023. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as the primary vehicle for providing a comprehensive range of...
The U.S. Department of Defense Defense Logistics Agency (DLA) awarded a delivery order contract to AmerisourceBergen Drug Corp in the amount of $1,211.69 for the supply of 4,565,334,227 Adderall XR 25 mg capsules. This delivery order is part of a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA Troop Support Medical, valued at up to $999,999,999 through December 2025, for the provision of a comprehensive range of medical commodities to support military treatment...
This federal contract award, with ID SPE2DX15D1053|SPE2DX25F6LQY, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The $1,382.46 delivery order contract is for the supply of 4,567,842,895 units of the prescription medication Adderall XR 10 mg capsules. The contract is a firm fixed-price, non-set-aside award with an ultimate completion date of April 9, 2025. Amerisourcebergen Drug Corp holds a substantial Indefinite Delivery...
This federal contract award, valued at $3,885.46, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order to supply 4,566,691,540 units of Adderall XR 20 mg capsules in 100-count bottles. The contract has a firm fixed-price pricing structure and is set to run through December 12, 2024. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with the DLA...
This federal contract award is to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of 4,564,325,670 units of Adderall XR 20 mg capsules. The contract, valued at $4,130.01, is a Firm Fixed Price Delivery Order awarded by the Defense Logistics Agency (DLA). The contract has an ultimate completion date of April 19, 2024. This award is not associated with a set-aside program. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,536.14 firm fixed-price delivery order is for the supply of 4,564,660,251 Adderall XR 10 mg capsules. The contract has a completion date of May 21, 2024 and was awarded on May 20, 2024. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
The federal contract award, valued at $4,561.45, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation. The delivery order contract is for the supply of 4,564,258,025 units of Adderall XR 20 mg capsules, a pharmaceutical product. This delivery order contract is part of a larger indefinite delivery contract (IDC) awarded solely to Amerisourcebergen Drug Corp, with a potential value of $999,999,999.00 and a performance period...
  • SPE2DB24D2100
    Indefinite Delivery Contract
  • SPE2DB24D2100-SPE2DB25FBDWQ
    Delivery Order

This federal contract award, valued at $2,198.76, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order for 4,568,072,869 units of Adderall XR 30 mg capsules, with a performance period extending through April 29, 2025.

Amerisourcebergen Drug Corp holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, designated as SPE2DX, which provides a comprehensive global pharmaceutical support vehicle through December 2026. This prime contract enables the company to supply a wide range of pharmaceutical products and medical supplies to support military healthcare programs worldwide, serving customers such as the Defense Health Agency and U.S. Coast Guard. The current delivery order is not designated as a set-aside contract.

Generated 7/28/25, 11:07 AM